[Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
D000818:Animals; D001786:Blood Glucose; D001892:Camphanes / Q000494:pharmacology / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006943:Hyperglycemia / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007328:Insulin / Q000008:administration & dosage; D050356:Lipid Metabolism; D010180:Pancreatectomy; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D014044:Tolbutamide / Q000494:pharmacology* / Q000627:therapeutic use; D014105:Tosyl Compounds / Q000627:therapeutic use
D001786:Blood Glucose; D001892:Camphanes; D003510:Cyclohexanes; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014105:Tosyl Compounds; D014044:Tolbutamide
Extrapankreatische Wirkungen von Sulfonylharnstoffen. II. Vergleich äquimolarer Konzentrationen von Tolbutamid, Glibornurid, Hydroxymethyltobutamid, Carboxytolbutamid und Carboxyglycyclamid hinsichtlich ihrer zusätzlichen blutzuckersenkenden und antilipolytischen Wirkung bei vollständig pankreatektomierten, chronisch mit Insulin behandelten Hunden.